SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19
Clinical trial NCT06050460 · UNKNOWN
Trial details
- NCT number
- NCT06050460
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-15
- Primary completion
- 2023-10-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.